Lactobacillus reuteri and indole-3-aldehyde (I3A) have been shown to modulate the tumor microenvironment via AHR, thereby enhancing anti-tumor immunity and optimizing immune checkpoint function in preclinical tumor models (10, 13, 26). The gene discussed is AHR; the disease is neoplasm.